Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Amerikaanse aandelen Terug naar discussie overzicht

Cannabis aandelen

8.264 Posts
Pagina: «« 1 ... 308 309 310 311 312 ... 414 »» | Laatste | Omlaag ↓
  1. HappynES 12 juli 2019 21:58
    Weet iemand wanneer de cijfers komen van Aurora, tgod en aleafia? Of een link naar waar je dat kan opzoeken?
  2. ldevo1 13 juli 2019 13:39
    quote:

    HappynES schreef op 12 juli 2019 21:58:

    Weet iemand wanneer de cijfers komen van Aurora, tgod en aleafia? Of een link naar waar je dat kan opzoeken?
    Aurora 24/09
    Tgod 28/08
    Aleafia 28/08

    Zie investing.com
  3. forum rang 10 DeZwarteRidder 14 juli 2019 14:18
    quote:

    ldevo1 schreef op 13 juli 2019 13:39:

    [...]Aurora 24/09
    Tgod 28/08
    Aleafia 28/08
    Zie investing.com
    De cijfers gaan gegarandeerd weer tegenvallen.
  4. Businessmen 15 juli 2019 08:43
    quote:

    Weetwel schreef op 12 juli 2019 20:27:

    [...]

    tussen 5-6$ overweeg ik ook een derde rit te maken
    Dat is 30, 40% minder dan de huidige koers terwijl de koers sinds top al 40% gezakt is. Ik denk niet dat dat realistisch is. Het is nu wel een mooi instap moment vind ik.
  5. wuiten001 17 juli 2019 18:32
    Update Harvest one:
    Harvest One Signs Supply Agreement with
    GenCanna for Extracted Products

    July 17, 2019 – Vancouver, British Columbia – Harvest One Cannabis Inc. (TSX-V: HVT; OTCQX: HRVOF) today announced that the Company, through its wholly-owned subsidiary, Satipharm Ltd., has entered into a Supply Agreement (the “Agreement”) with GenCanna Global USA, dated June 4, 2019. Under the terms of the Agreement, GenCanna will supply Harvest One with GMP Certified CBD oil and finished products for distribution in regulated markets in the United States, Europe, and around the globe, currently under the Dream Water, Satipharm, and LivRelief™ brands for an initial term of two years. In addition, GenCanna will support the Company in the research, development, and formulation of both existing and new CBD-infused products.

    With an industry-leading 38,000+ retail distribution points around the globe (including, Walmart US, CVS, Kroger, Shoppers Drug Mart, Loblaw, Holland & Barrett and Boots), Harvest One is quickly becoming a leading global house of brands in the health, wellness, and self-care sectors, with cannabis, cannabis-infused, and all-natural product offerings. From Satipharm’s patented GelPell® CBD capsules, to Dream Water’s all natural, single shot sleep products, and the recent addition of LivRelief™, Canada’s leading all natural topical pain relief cream, the Agreement with GenCanna ensures the consistent supply of premium quality hemp-derived CBD for infusion of our existing products and further product innovation.

    “Working with world-class partners like GenCanna to supply premium quality, traceable, consistent ingredients, all from GMP-certified facilities, is critical to our core strategy at Harvest One to only offer consumers best-in-class premium products, with consistent and predictable effects, in delivery formats they have come to understand and demand” said Grant Froese, Chief Executive Officer of Harvest One. Mr. Froese added, “this Agreement signals the beginning of a global relationship with GenCanna under which we will continue to innovate, infuse our existing portfolio of products, and bring new products to market under our well-recognized and trusted, Satipharm, Dream Water, and LivRelief™ brands”.

    “Our evolving relationship with Harvest One reflects both companies’ devotion to consumer product quality” said Steve Bevan, Executive Chair of GenCanna. “Joint research and development have combined to provide excellent CBD product additions to Harvest One’s suite of leading-edge brands. We expect that consumers will quickly welcome these products on retail shelves globally” added Steve Bevan.


    Under the terms of the Agreement, GenCanna will provide a production platform that uses innovative, proprietary harvesting and crop processing technologies that produce unmatched purity and quality. This will allow Harvest One and their brands around the world to access a consistent and fully compliant stable supply of hemp derived CBD extract and products that consumers and patients can count on.

    About Harvest One Cannabis Inc.

    Harvest One is a global consumer packaged goods company that develops and distributes premium health, wellness, and lifestyle products to patients and consumers in regulated markets around the world. The Company's portfolio of premium products is designed to enhance quality of life. Shareholders have significant exposure to the entire cannabis value chain through four wholly-owned subsidiaries: United Greeneries, a Licensed Producer; Satipharm (medical and nutraceutical); Dream Water Global and Delivra (consumer products with an emphasis on sleep, pain, and anxiety), and a minority interest in Burb Cannabis (retail operations). For more information, please visit www.harvestone.com.

    About GenCanna

    GenCanna is a vertically-integrated agriculture-technology company specializing in the production of high quality hemp-derived CBD. Founded in 2014, as an inaugural member of the Kentucky Department of Agriculture’s Industrial Hemp Pilot Program, the company is a longstanding industry pioneer. GenCanna works closely with state universities, consumer protection agencies and other regulatory bodies driving key industry language and legislation. Consistent extraction methods and innovative processing technologies ensure GenCanna production processes exceed all regulatory standards for FDA registered and inspected food production facilities (learn more at gencanna.com/compliance/). The GenCanna Production Platform™ assures standardized, repeatable quality from farm to finished product.

    Cautionary Note Regarding Forward-Looking Statements

    Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. The forward-looking information contained in this press release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
    Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.

  6. mexico 18 juli 2019 14:29
    quote:

    DeZwarteRidder schreef op 14 juli 2019 14:18:

    [...]
    De cijfers gaan gegarandeerd weer tegenvallen.
    Zulke uitspraken geven het niveau van poster aan!!!!
    "GEGARANDEERD" bestaat niet in beursvoorspellingen!!!
  7. forum rang 10 DeZwarteRidder 18 juli 2019 15:05
    quote:

    mexico schreef op 18 juli 2019 14:29:

    [...]
    Zulke uitspraken geven het niveau van poster aan!!!!
    "GEGARANDEERD" bestaat niet in beursvoorspellingen!!!
    Je hebt gelijk: ik verander het in 'zeer waarschijnlijk'.
  8. forum rang 4 Guuster 19 juli 2019 21:53
    quote:

    Businessmen schreef op 15 juli 2019 16:28:

    [...]

    Nice gerelateerde aandelen gaan ook lekker omhoog.
    Het wil nog niet echt vlotten. Als ‘ie niet rap tot boven de 10 euro klimt dan gooi ik ‘m eruit.
  9. wuiten001 21 juli 2019 13:16
    Zijn er hier mensen die (gefundeerde, realistische) verwachtingen bij Aurora of tgod in de nabije toekomst hebben?
  10. forum rang 4 Guuster 21 juli 2019 22:14
    quote:

    wuiten001 schreef op 21 juli 2019 13:16:

    Zijn er hier mensen die (gefundeerde, realistische) verwachtingen bij Aurora of tgod in de nabije toekomst hebben?
    Hoi Wuiten, lekker bij Gala blijven man. Anders Aurora bescheiden proberen. Zijn flink gekelderd. Zij richten zich vooral op medicinale toepassingen. Kweken voor recreatief gebruik kan iedere halve zool.
  11. wuiten001 21 juli 2019 22:49
    quote:

    Guuster schreef op 21 juli 2019 22:14:

    [...]
    Hoi Wuiten, lekker bij Gala blijven man. Anders Aurora bescheiden proberen. Zijn flink gekelderd. Zij richten zich vooral op medicinale toepassingen. Kweken voor recreatief gebruik kan iedere halve zool.
    Aurora heb ik al heel lang in bezit maar staan zodanig in het rood dat ik begin te twijfelen om ze te verkopen.........idd, voor Gala.....ook tgod in bezit.
  12. forum rang 4 Guuster 22 juli 2019 23:32
    Aurora had toch een topper in de directie aangetrokken die bekend staat om het sluiten van mooie allianties? Dat is de enige reden waarom ik deze bak ellende er nog niet uitgooi. Want du moment dat je dat doet gaat er natuurlijk een PB dienaangaande uit
  13. forum rang 10 DeZwarteRidder 22 juli 2019 23:52
    Aurora heeft een beurswaarde van ca 9 MILJARD bij een jaaromzet van ca 65 MILJOEN......!!!

    Dus iedereen begrijpt wat er met de koers gaat gebeuren.
  14. forum rang 4 Guuster 23 juli 2019 00:29
    quote:

    DeZwarteRidder schreef op 22 juli 2019 23:52:

    Aurora heeft een beurswaarde van ca 9 MILJARD bij een jaaromzet van ca 65 MILJOEN......!!!

    Dus iedereen begrijpt wat er met de koers gaat gebeuren.
    Ik heb deze positie mentaal al afgeschreven ZwarteRidder
8.264 Posts
Pagina: «« 1 ... 308 309 310 311 312 ... 414 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.840
AB InBev 2 5.285
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.579 46.244
ABO-Group 1 18
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 8.887
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 31
Adomos 1 126
AdUX 2 457
Adyen 13 16.175
Aedifica 2 829
Aegon 3.257 320.032
AFC Ajax 537 7.013
Affimed NV 2 5.751
ageas 5.843 109.777
Agfa-Gevaert 13 1.856
Ahold 3.536 73.979
Air France - KLM 1.024 34.307
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.761
Alfen 12 16.160
Allfunds Group 3 1.179
Almunda Professionals (vh Novisource) 651 4.246
Alpha Pro Tech 1 17
Alphabet Inc. 1 326
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.484 114.757
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.819 240.226
AMG 965 125.627
AMS 3 73
Amsterdam Commodities 303 6.515
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 382
Antonov 22.632 153.605
Aperam 91 14.108
Apollo Alternative Assets 1 17
Apple 5 313
Arcadis 251 8.613
Arcelor Mittal 2.023 318.590
Archos 1 1
Arcona Property Fund 1 266
arGEN-X 15 9.101
Aroundtown SA 1 176
Arrowhead Research 5 9.257
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.641
ASML 1.762 76.795
ASR Nederland 18 4.122
ATAI Life Sciences 1 7
Atenor Group 1 324
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.644
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.660

Macro & Bedrijfsagenda

  1. 25 april

    1. BASF Q1-cijfers
    2. Deutsche Bank Q1-cijfers
    3. Delivery Hero Q1-cijfers
    4. Nestlé Q1-cijfers
    5. Adyen Q1-cijfers
    6. Besi Q1-cijfers
    7. Flow Traders Q1-cijfers
    8. Sanofi Q1-cijfers
    9. Azelis Q1-cijfers
    10. Kinepolis Q1-cijfers
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht